[Protective role of Eleutherococcus during the administration of rubomycia under experimental conditions].
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000037:antagonists & inhibitors / Q000633:toxicity; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation / Q000187:drug effects*; D000921:Antibody-Producing Cells / Q000187:drug effects; D002452:Cell Count; D003864:Depression, Chemical; D006168:Guinea Pigs; D007958:Leukocyte Count; D007970:Leukopenia / Q000517:prevention & control; D008089:Listeria monocytogenes; D051379:Mice; D009929:Organ Size; D010587:Phagocytosis / Q000187:drug effects*; D010936:Plant Extracts / Q000008:administration & dosage; D010946:Plants, Medicinal; D013154:Spleen / Q000033:anatomy & histology / Q000166:cytology / Q000187:drug effects; D013268:Stimulation, Chemical; D013950:Thymus Gland / Q000033:anatomy & histology / Q000187:drug effects
D000903:Antibiotics, Antineoplastic; D000906:Antibodies; D010936:Plant Extracts
O zashchitnoĭ roli eleuterokokka pri vvedenii rubomitsina v eksperimente.